Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study.
Luca ValerioAnna C MavromanoliAlexandru GrigoreanChristina AbeleDorothea BeckerLeonhard BruchRalf EwertMartin FaehlingDavid FisteraFelix GerhardtHossein Ardeschir GhofraniAleksandar GrgicEkkehard GrünigMichael HalankMatthias HeldLukas HobohmMarius M HoeperFrederikus A KlokMareike LankeitHanno H LeuchteNadine MartinEckhard MayerF Joachim MeyerClaus NeurohrChristian OpitzKai Helge SchmidtHans Jürgen SeyfarthRolf WachterHeinrike WilkensPhilipp S WildStavros V KonstantinidesStephan Rosenkranznull nullPublished in: European heart journal (2022)
In this prospective study, the cumulative 2-year incidence of CTEPH was 2.3%, but PPEI diagnosed by standardized criteria was frequent. Our findings support systematic follow-up of patients after acute PE and may help to optimize guideline recommendations and algorithms for post-PE care.
Keyphrases
- pulmonary embolism
- pulmonary hypertension
- end stage renal disease
- healthcare
- inferior vena cava
- newly diagnosed
- ejection fraction
- chronic kidney disease
- machine learning
- palliative care
- prognostic factors
- peritoneal dialysis
- risk factors
- deep learning
- clinical practice
- coronary artery
- pain management
- pulmonary arterial hypertension